Home > News > US-based CytImmune gears up to target cancer cure
June 18th, 2007
US-based CytImmune gears up to target cancer cure
We all know there is no magic bullet for cancer. But scientists across the world are working on novel projects like cancer vaccines and newer tools like nanotechnology to conquer cancer, reports CNBC-TV18.
CytImmune is a small US-based nanotechnology company, but it has set a big goal for itself. CytImmune scientists are developing a nanotechnology-based Drug Delivery System that can target cancerous tumours leaving healthy organs and tissues untouched.
Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results April 27th, 2017
New Product Nanoparticle preparation from Intertronics with new Thinky NP-100 Nano Pulveriser April 26th, 2017
Nanoparticle vaccine shows potential as immunotherapy to fight multiple cancer types April 24th, 2017
Arrowhead Presents ARC-520 and ARC-521 Clinical Data at The International Liver Congress(TM) April 20th, 2017
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Ultracold atom waves may shed light on rogue ocean killers: Rice quantum experiments probe underlying physics of rogue ocean waves April 27th, 2017
Looking for the quantum frontier: Beyond classical computing without fault-tolerance? April 27th, 2017
Metal nanoparticles induced visible-light photocatalysis: Mechanisms, applications, ways of promoting catalytic activity and outlook April 27th, 2017
Video captures bubble-blowing battery in action: Researchers propose how bubbles form, could lead to smaller lithium-air batteries April 26th, 2017